These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 1483294
1. Characterization of big, big prolactin in patients with hyperprolactinaemia. Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG. Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294 [Abstract] [Full Text] [Related]
2. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F. Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926 [Abstract] [Full Text] [Related]
7. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay. Rose DP, Berke B, Cohen LA. Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857 [Abstract] [Full Text] [Related]
8. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Hattori N, Nakayama Y, Kitagawa K, Ishihara T, Saiki Y, Inagaki C. Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026 [Abstract] [Full Text] [Related]
9. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Olukoga AO, Kane JW. Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974 [Abstract] [Full Text] [Related]
12. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Pinto LP, Hanna FW, Evans LM, Davies JS, John R, Scanlon MF. Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880 [Abstract] [Full Text] [Related]
13. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity. Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159 [Abstract] [Full Text] [Related]
14. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin. Subramanian MG, Spirtos NJ, Moghissi KS, Magyar DM, Hayes MF, Gala RR. Fertil Steril; 1984 Dec; 42(6):870-4. PubMed ID: 6500079 [Abstract] [Full Text] [Related]
15. Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms. Guitelman M, Colombani-Vidal ME, Zylbersztein CC, Fiszlejder L, Zeller M, Levalle O, Scaglia HE. Pituitary; 2002 Dec; 5(4):255-60. PubMed ID: 14558674 [Abstract] [Full Text] [Related]
16. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states. Smith CR, Butler J, Hashim I, Norman MR. Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154 [Abstract] [Full Text] [Related]
17. The natural history of macroprolactinaemia. Hattori N, Adachi T, Ishihara T, Shimatsu A. Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016 [Abstract] [Full Text] [Related]
18. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function. Larrea F, Escorza A, Valero A, Hernandez L, Cravioto MC, Diaz-Sanchez V. J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295 [Abstract] [Full Text] [Related]
19. Demonstration of biological activity of prolactin molecular weight variants in human sera. Whitaker MD, Klee GG, Kao PC, Randall RV, Heser DW. J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188 [Abstract] [Full Text] [Related]
20. Macroprolactinemia: clinical significance and characterization of the condition. Theunissen C, De Schepper J, Schiettecatte J, Verdood P, Hooghe-Peeters EL, Velkeniers B. Acta Clin Belg; 2005 May; 60(4):190-7. PubMed ID: 16279400 [Abstract] [Full Text] [Related] Page: [Next] [New Search]